Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention

被引:96
|
作者
Tong, Xin [1 ]
Pelling, Jill C.
机构
[1] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA
关键词
Akt; mTOR; apigenin; cancer; CELL-CYCLE ARREST; CHEMOPREVENTIVE BIOFLAVONOID APIGENIN; CYCLOOXYGENASE-2; COX-2; EXPRESSION; SIGNAL-TRANSDUCTION PATHWAYS; GLUTATHIONE-S-TRANSFERASE; HUMAN PANCREATIC-CANCER; CYTOCHROME-C RELEASE; FLAVONOID APIGENIN; DIETARY FLAVONOIDS; TUMOR-CELLS;
D O I
10.2174/18715206113139990119
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural products are important sources of anti-cancer lead molecules, and high dietary consumption of fruits and vegetables is associated with a reduced risk of certain cancers. Many efforts have been devoted to identifying and developing plant-derived dietary constituents as chemopreventive agents. Among them, apigenin, a naturally occurring flavonoid found in a variety of fruits and leafy vegetables, has been shown to possess remarkable anti-oxidant, anti-inflammatory and anti-carcinogenic properties. This review summarizes the anti-cancer and chemopreventive effects of apigenin at cellular and molecular levels, its chemical structure and properties, with focus on mechanism related to apigenin's inhibition of the PI3K/Akt/mTOR signaling pathways.
引用
收藏
页码:971 / 978
页数:8
相关论文
共 50 条
  • [41] Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
    Nunnery, Sara E.
    Mayer, Ingrid A.
    DRUGS, 2020, 80 (16) : 1685 - 1697
  • [42] Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
    Fumarola, Claudia
    Bonelli, Mara A.
    Petronini, Pier Giorgio
    Alfieri, Roberta R.
    BIOCHEMICAL PHARMACOLOGY, 2014, 90 (03) : 197 - 207
  • [43] Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach
    Zughaibi, Torki A.
    Suhail, Mohd
    Tarique, Mohammad
    Tabrez, Shams
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [44] Targeting PI3K/Akt/mTOR signaling pathway by polyphenols: Implication for cancer therapy
    Mirza-Aghazade, Mohammad
    Ekrami, Elyad Mohammadi
    Aghdas, Seyyed Ali Mousavi
    Mihanfar, Ainaz
    Hallaj, Shahin
    Yousefi, Bahman
    Safa, Amin
    Majidinia, Maryam
    LIFE SCIENCES, 2020, 255
  • [45] Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance
    Chang, Lei
    Graham, Peter H.
    Ni, Jie
    Hao, Jingli
    Bucci, Joseph
    Cozzi, Paul J.
    Li, Yong
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (03) : 507 - 517
  • [46] Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
    Li, Qingfang
    Li, Zhihui
    Luo, Ting
    Shi, Huashan
    MOLECULAR BIOMEDICINE, 2022, 3 (01):
  • [47] Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
    Bang, Jieun
    Jun, Mihyeon
    Lee, Soyun
    Moon, Hyuk
    Ro, Simon Weonsang
    PHARMACEUTICS, 2023, 15 (08)
  • [48] TARGETING THE PI3K/AKT/MTOR SIGNALING PATHWAYS IN CYSTIC FIBROSIS
    Reilly, R.
    Mroz, M.
    Dempsey, E.
    Shields, S.
    Wynne, K.
    McKone, E. F.
    Hiebel, C.
    Behl, C.
    Coppinger, J.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 200 - 200
  • [49] Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
    Darici, Salihanur
    Alkhaldi, Hazem
    Horne, Gillian
    Jorgensen, Heather G.
    Marmiroli, Sandra
    Huang, Xu
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 40
  • [50] Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
    R. Reilly
    M. S. Mroz
    E. Dempsey
    K. Wynne
    S. J. Keely
    E. F. McKone
    C. Hiebel
    C. Behl
    J. A. Coppinger
    Scientific Reports, 7